Undervalued Drug Manufacturer Stocks on TSE September 2024

September 14, 2024

Drug Manufacturers

Drug Manufacturers are engaged in pharmaceutical manufacturing or sale of a diverse line of drug and healthcare products. This industry group also includes companies engaged in the development and discovery of new dugs, and tobacco and cannabis companies.

Toronto Stock Exchange

The Toronto Stock Exchange (TSE) is a stock exchange located in Toronto, Ontario, Canada. It is the 10th largest exchange in the world and the third largest in North America based on market capitalization.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Drug Manufacturers stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
VPH Valeo Pharma 0.07 0.18 176.03 52674 6 0.00 0.0
AVNT Avant Brands 1.14 2.41 111.59 6748 11 0.00 0.0
TSND TerrAscend 1.59 3.21 101.71 179657 463 0.00 0.0
XLY Auxly Cannabis Group 0.04 0.07 67.29 408097 52 0.00 0.0
CRON Cronos Group 2.96 4.93 66.52 103593 1131 0.00 0.0
TLRY Tilray Brands 2.37 3.88 63.92 846767 1760 0.00 0.0
CWEB Charlottes Web Holdings 0.20 0.33 61.68 41201 32 0.00 0.0
LABS MediPharm Labs 0.06 0.10 59.27 117952 24 0.00 0.0
OGI OrganiGram Holdings 2.52 3.41 35.23 247205 273 0.00 0.0
DHT.U DRI Healthcare Trust 8.96 11.86 32.32 641 506 3.57 0.0
All data provided as at market close September 12, 2024.

Company Details

Valeo Pharma

VPH:TSX

Close Price

0.07

Our Valuation

0.18

% Difference

176.03

Market Cap ($M)

6

P/E Ratio

0.0

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Access the stockcalc valuation


Avant Brands

AVNT:TSX

Close Price

1.14

Our Valuation

2.41

% Difference

111.59

Market Cap ($M)

11

P/E Ratio

0.0

Avant Brands Inc is an innovative premium cannabis company. It has multiple licensed and operational production facilities across Canada, which produce high-quality, handcrafted cannabis products for highly desired, and award-winning consumer brands, sold across both recreational and medical channels. The company's diverse product range is distributed through three distinct sales channels: recreational, medical, and export.

Access the stockcalc valuation


TerrAscend

TSND:TSX

Close Price

1.59

Our Valuation

3.21

% Difference

101.71

Market Cap ($M)

463

P/E Ratio

0.0

TerrAscend Corp is a company focused on creating and delivering quality cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. It has one operating segment, being cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States.

Access the stockcalc valuation


Auxly Cannabis Group

XLY:TSX

Close Price

0.04

Our Valuation

0.07

% Difference

67.29

Market Cap ($M)

52

P/E Ratio

0.0

Auxly Cannabis Group Inc is a consumer-packaged-goods company in the cannabis products market. The company's focus is on developing, manufacturing, and distributing branded cannabis products. The group activities operate through two segments which include Canadian Cannabis operations, and South American Cannabis operations.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Cronos Group

CRON:TSX

Close Price

2.96

Our Valuation

4.93

% Difference

66.52

Market Cap ($M)

1131

P/E Ratio

0.0

Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

Access the stockcalc valuation


Tilray Brands

TLRY:TSX

Close Price

2.37

Our Valuation

3.88

% Difference

63.92

Market Cap ($M)

1760

P/E Ratio

0.0

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Access the stockcalc valuation


Charlottes Web Holdings

CWEB:TSX

Close Price

0.20

Our Valuation

0.33

% Difference

61.68

Market Cap ($M)

32

P/E Ratio

0.0

Charlottes Web Holdings Inc is engaged in the production and distribution of hemp-based cannabidiol (CBD) wellness products. Its product categories include ingestible products (tinctures, capsules, and gummies), topicals, and pet products. The company distributes its products through an e-commerce website, third-party e-commerce websites, select distributors, health practitioners, and a variety of brick-and-mortar specialty retailers.

Access the stockcalc valuation


MediPharm Labs

LABS:TSX

Close Price

0.06

Our Valuation

0.10

% Difference

59.27

Market Cap ($M)

24

P/E Ratio

0.0

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets.

Access the stockcalc valuation


OrganiGram Holdings

OGI:TSX

Close Price

2.52

Our Valuation

3.41

% Difference

35.23

Market Cap ($M)

273

P/E Ratio

0.0

OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.

Access the stockcalc valuation


DRI Healthcare Trust

DHT.U:TSX

Close Price

8.96

Our Valuation

11.86

% Difference

32.32

Market Cap ($M)

506

P/E Ratio

0.0

DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Valeo Pharma and Avant Brands are the most undervalued Drug Manufacturers stocks on the TSE. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-tse-september-2024
Valeo Pharma $VPH and Avant Brands $AVNT are the most undervalued Drug Manufacturers stocks on the #TSE. See the full list: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-tse-september-2024
Valeo Pharma and Avant Brands are the most undervalued Drug Manufacturers stocks on the TSE. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-tse-september-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.